Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
80.46
+3.59 (4.67%)
At close: Mar 9, 2026, 4:00 PM EDT
78.86
-1.60 (-1.99%)
After-hours: Mar 9, 2026, 7:06 PM EDT
Bright Minds Biosciences Employees
Bright Minds Biosciences had 26 employees as of September 30, 2025. The number of employees increased by 25 or 2,500.00% compared to the previous year.
Employees
26
Change (1Y)
25
Growth (1Y)
2,500.00%
Revenue / Employee
n/a
Profits / Employee
-$556,655
Market Cap
793.06M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 26 | 25 | 2,500.00% |
| Sep 30, 2024 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MannKind | 592 |
| Gyre Therapeutics | 579 |
| Prime Medicine | 214 |
| ProKidney | 204 |
| Kura Oncology | 192 |
| CytomX Therapeutics | 121 |
| Lexicon Pharmaceuticals | 103 |
| Annexon | 99 |
DRUG News
- 12 days ago - Bright Minds Biosciences to Present at Upcoming Conferences - GlobeNewsWire
- 20 days ago - BTIG Maintains Buy Rating for Bright Minds Biosciences (DRUG) with $147 Target | DRUG Stock News - GuruFocus
- 2 months ago - Bright Minds Biosciences Announces Closing of US$175 Million Public Offering - GlobeNewsWire
- 2 months ago - Bright Minds Biosciences (DRUG) Prices $175M Public Offering - GuruFocus
- 2 months ago - Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock - GlobeNewsWire
- 2 months ago - Bright Minds Biosciences: Positive BREAKTHROUGH Study Data Warrants 'Strong Buy' Rating - Seeking Alpha
- 2 months ago - Bright Minds Biosciences, Praxis Precision Medicines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
- 2 months ago - Bright Minds Biosciences launches $100 million public offering - Seeking Alpha